Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
03 October 2018 | Story UFS | Photo Katlego Sekele
Empowering students to speak up about sexual violations
Students engaged authorities and Student Affairs representatives on sexual and gender-based matters.


Do you know enough about the Sexual Harassment, Sexual Misconduct and Sexual Violence policy adopted by the university in June 2018? The Office for Gender and Sexual Equity (GSE) at the University of the Free State (UFS) hosted a dialogue on the role of the institution in matters of sexual and gender-based violence and addressing issues surrounding sexual violations. 

Developments such as the countrywide #TotalShutdown: Intersectional Women’s March Against Gender-based Violence last month serve as proof of the dire need for issues surrounding sexual violations to inform policies and active safety measures.

Policy purpose

According to the policy, the objectives are to create a safe and enabling environment, establish a common understanding of what constitutes sexual harassment, sexual misconduct and sexual violence, provide applicable and accurate information, ensure that victims receive the necessary support, clearly outline disciplinary procedures for perpetrators, and clarify institutional accountability.

Student’s take on solutions

Tammy Fray, a member of the Student Representative Council, who formed part of the panel at the discussion, says the policy is not a one-stop-shop solution. “The policy is a guiding document. We have to then use it to inform activist work. We cannot always put the onus on policies and codes of conducts to solve problems. However it is our responsibility within this academic space to come up with solutions that enhance the way the policy works.”

Be informed about the policy

It is important to understand the stipulations of the policy in order to make full use of it. Geraldine Lengau, Officer at the GSE said: “It’s important that students know that the institution is not operating in silos but that their demands have been heard and the institution has acknowledged that there is a need for the policy to be adopted. It also makes the process of reporting better with the assistance of the Sexual Assault Response Team coordinator.”

News Archive

#Women'sMonth: Save the children
2017-08-10

Description: Trudi O'Neill Tags: : rotaviruses, young children, Dr Trudi O’Neill, Department of Microbial, Biochemical and Food Biotechnology, vaccine 

Dr Trudi O’Neill, Senior lecturer in the Department of
Microbial, Biochemical and Food Biotechnology.
Photo: Anja Aucamp

Dr Trudi O’Neill, Senior lecturer in the Department of Microbial, Biochemical and Food Biotechnology, is conducting research on rotavirus vaccines.

Dr O’Neill was inspired to conduct research on this issue through her fascination with the virus. “The biology of rotaviruses, especially the genome structure and the virus’ interaction with the host, is fascinating.”

“In fact, it is estimated that, globally, ALL children will be infected with rotavirus before the age of five, irrespective of their socio-economic standing. However, infants and young children in poor countries are more vulnerable due to inadequate healthcare. The WHO estimates that approximately 215 000 deaths occur each year. This roughly equates to eight Airbus A380 planes, the largest commercial carrier with a capacity of approximately 500 seats, filled with only children under the age of five, crashing each week of every year.”

Alternative to expensive medicines 
“Currently, there are two vaccines that have been licensed for global use. However, these vaccines are expensive and poor countries, where the need is the greatest, are struggling to introduce them sustainably. It is therefore appealing to study rotaviruses, as it is scientifically challenging, but could at the same time have an impact on child health,” Dr O’Neill said.

The main focus of Dr O’Neill’s research is to develop a more affordable vaccine that can promote child vaccination in countries/areas that cannot afford the current vaccines.

All about a different approach 

When asked about the most profound finding of her research, Dr O’Neill responded: “It is not so much a finding, but rather the approach. My rotavirus research group is making use of yeast as vehicle to produce a sub-unit vaccine. These microbes are attractive, as they are relatively easy to manipulate and cheap to cultivate. Downstream production costs can therefore be reduced. The system we use was developed by my colleagues, Profs Koos Albertyn and Martie Smit, and allows for the potential use of any yeast. This enables us to screen a vast number of yeasts in order to identify the best yeast producer.”

Vaccination recently acquired a bad name in the media for its adverse side effects. As researcher, Dr O’Neill has this to say: “Vaccines save lives. By vaccinating your child, you don’t just protect your own child from a potentially deadly infection, but also other children in your community that might be too young to be vaccinated or have pre-existing health problems that prevents vaccination.” 

A future without rotavirus vaccination?

Dr O’Neill believes a future without rotavirus vaccination will be a major step backwards, as the impact of rotavirus vaccines has been profound. “Studies in Mexico and Malawi actually show a reduction in deaths. A colleague in Mozambique has commented on the empty hospital beds that amazed both clinicians and scientists only one year after the introduction of the vaccine in that country. Although many parents, mostly in developed countries, don’t have to fear dehydrating diarrhoea and potential hospitalisation of their babies due to rotavirus infection anymore, such an infection could still be a death sentence in countries that have not been able to introduce the vaccine in their national vaccination programmes,” she said. 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept